Study record

The Relationship Between MOTS-c K14Q Polymorphism and Sarcopenia, Blood Lipids, and Mental Health in Older Korean Adults

Kim S · Biomedicines · 2024

Human obs.MT-RNR1 / K14Q variantEvidence tier B

What this study reported

Found higher appendicular skeletal muscle mass, lean mass and handgrip strength in older Korean men carrying the C allele than in A-allele carriers, with the differences persisting after covariate adjustment. No significant genotype differences were found in women or in blood lipids and mental health measures.

Limitations

Cross-sectional, single-ethnicity sample with few C-allele carriers; many outcomes tested; muscle mass estimated rather than imaged directly.

Study record

Annotated fields for this study
Study modelHuman observational
Substance studiedMT-RNR1 / K14Q variantStudies of the m.1382A>C (K14Q) variant or other MT-RNR1 variation.
Specieshuman
System studiedm.1382A>C (K14Q) genotype and sarcopenia measures in community-dwelling Korean adults aged 65 years and older
Population683 community-dwelling Korean adults aged 65 years and older
DesignCross-sectional cohort
Sample size as reported683 adults (345 men, 338 women)
Control groupcarriers of the A allele
Route (data field only)Not reported
Endpoints measuredappendicular skeletal muscle mass; handgrip strength; lean mass; blood lipids; cognitive function and depression
Pathways measuredNot reported
Research areasAging · Skeletal muscle
Evidence tierB — Other human study
Publication typesJournal Article

Appraisal

Each dimension is recorded separately and never combined into a single score. A study can be well controlled and still tell you little about people.

Relevance to MOTS-c
Direct
Model applicability
Human
Sample size
Adequate
Controls
Appropriate
Outcome validity
Validated biomarker
Support for its own conclusion
Moderate

Provenance

  • Bibliographic fields retrieved from PubMed E-utilities efetch (title, journal, date, authors, DOI) on 2026-11-11.
  • Annotated from the published abstract.
  • Editorial review: approved (2026-11-11).
  • Classification follows the site methodology; the record describes the study, not what MOTS-c does in people.